Pfizer-commissioned report says CMS can reinterpret existing law to permit coverage of new anti-obesity medicines in Medicare Part D. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
